Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 21NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 17Burkitt Lymphoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Rectal Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lung Neoplasms 2Leukemia, Biphenotypic, Acute 2Immunoglobulin Light-chain Amyloidosis 2Down Syndrome 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Rhabdoid Tumor 1Recurrence 1Prolactinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Pituitary Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Mesothelioma 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

Melphalan 20Cyclophosphamide 17Dexamethasone 14Peripheral Blood Stem Cell Transplantation 12Filgrastim 9sargramostim 8fludarabine phosphate 7Interferon-alpha 7Busulfan 7Bortezomib 7Vincristine 6Thalidomide 6Prednisone 6Doxorubicin 5Antilymphocyte Serum 5Radiotherapy 4Cyclosporine 4Mycophenolic Acid 3Methylprednisolone 3Idarubicin 3Etoposide 3Drug Therapy 3Ascorbic Acid 3Arsenic Trioxide 3Rituximab 2Methotrexate 2Interleukin-12 Subunit p35 2Ifosfamide 2Cytarabine 2Carmustine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neoplasms, Plasma Cell × Calcium Dobesilate × Clear all
NCT00075829 2021-11-01

BMT CTN 0102

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
710 enrolled 19 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡